Claire Smith

1.5k total citations
28 papers, 1.1k citations indexed

About

Claire Smith is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Claire Smith has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Claire Smith's work include TGF-β signaling in diseases (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Claire Smith is often cited by papers focused on TGF-β signaling in diseases (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Claire Smith collaborates with scholars based in United States, United Kingdom and France. Claire Smith's co-authors include Karim A. Benhadji, Ann Cleverly, Michael Lahn, Ivelina Gueorguieva, Jordi Rodón, Shawn T. Estrem, Eunice Yuen, Jörg Trojan, Mark Kozloff and Teresa Macarulla and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Claire Smith

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claire Smith United States	14	606	482	227	189	115	28	1.1k
Jennifer M. Tran United States	12	377 0.6×	909 1.9×	209 0.9×	296 1.6×	70 0.6×	21	1.3k
Severino Montemurro Italy	16	353 0.6×	404 0.8×	201 0.9×	151 0.8×	76 0.7×	35	901
Nicole E. Willmarth United States	17	496 0.8×	671 1.4×	164 0.7×	390 2.1×	62 0.5×	23	1.2k
Vanesa Santos Spain	12	308 0.5×	800 1.7×	173 0.8×	225 1.2×	45 0.4×	18	1.0k
Zhenhua Zhai China	14	484 0.8×	685 1.4×	138 0.6×	356 1.9×	201 1.7×	22	1.4k
Mikinori Sato Japan	19	704 1.2×	603 1.3×	214 0.9×	302 1.6×	38 0.3×	59	1.4k
Sameer Doshi United States	18	417 0.7×	252 0.5×	190 0.8×	58 0.3×	126 1.1×	48	1.0k
Ricardo Costa Brazil	16	403 0.7×	504 1.0×	111 0.5×	299 1.6×	46 0.4×	17	1.1k
Beverly L. Falcón United States	16	435 0.7×	804 1.7×	110 0.5×	339 1.8×	68 0.6×	34	1.4k
Andrea Malfettone Spain	23	664 1.1×	705 1.5×	206 0.9×	358 1.9×	79 0.7×	53	1.5k

Countries citing papers authored by Claire Smith

Since Specialization

Citations

This map shows the geographic impact of Claire Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Smith more than expected).

Fields of papers citing papers by Claire Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Smith. The network helps show where Claire Smith may publish in the future.

Co-authorship network of co-authors of Claire Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Smith. A scholar is included among the top collaborators of Claire Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Smith. Claire Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spira, Alexander I., James Y. Lau, Maureen M. Hattersley, et al.. (2024). PRIMROSE: A modular phase 1/2a study of AZD3470, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP deficient advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS3179–TPS3179. 6 indexed citations

Kim, Seung Tae, Simon A. Smith, Peter G. Mortimer, et al.. (2021). Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer. Clinical Cancer Research. 27(17). 4700–4709. 61 indexed citations

Giannelli, Gianluigi, Armando Santoro, Robin Kate Kelley, et al.. (2021). Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. PLoS ONE. 16(6). e0253671–e0253671. 2 indexed citations

Giannelli, Gianluigi, Armando Santoro, Robin Kate Kelley, et al.. (2020). Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib. PLoS ONE. 15(3). e0222259–e0222259. 46 indexed citations

Robertson-Plouch, Carol, John R. Stille, Peng Liu, et al.. (2019). A randomized clinical efficacy study targeting mPGES1 or EP4 in dogs with spontaneous osteoarthritis. Science Translational Medicine. 11(516). 13 indexed citations

Even, Caroline, Ulrik Lassen, Jaime R. Merchan, et al.. (2019). Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma. Investigational New Drugs. 38(2). 402–409. 56 indexed citations

Faivre, Sandrine, Armando Santoro, Robin Kate Kelley, et al.. (2019). Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma. Liver International. 39(8). 1468–1477. 114 indexed citations

Melisi, Davide, Rocio García‐Carbonero, Teresa Macarulla, et al.. (2019). TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer. Cancer Chemotherapy and Pharmacology. 83(5). 975–991. 77 indexed citations

Massard, Christophe, Jean‐Charles Soria, Ulrik Lassen, et al.. (2018). First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer. Annals of Oncology. 29(9). 1911–1917. 107 indexed citations

10.

Melisi, Davide, Rocio García‐Carbonero, Teresa Macarulla, et al.. (2018). Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. British Journal of Cancer. 119(10). 1208–1214. 224 indexed citations

11.

Cole, Eric S., Mark Li, Claire Smith, et al.. (2018). Restoration of cellular integrity following “ballistic” pronuclear exchange during Tetrahymena conjugation. Developmental Biology. 444(1). 33–40. 1 indexed citations

12.

Yuen, Eunice, et al.. (2018). Evaluation of the effects of an oral notch inhibitor, crenigacestat (LY3039478), on QT interval, and bioavailability studies conducted in healthy subjects. Cancer Chemotherapy and Pharmacology. 83(3). 483–492. 7 indexed citations

13.

Jin, Yan, Claire Smith, David Monteith, et al.. (2018). CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial. Osteoarthritis and Cartilage. 26(12). 1609–1618. 40 indexed citations

14.

Smith, Claire, Yan Jin, Eyas Raddad, et al.. (2018). Applications of Bayesian statistical methodology to clinical trial design: A case study of a phase 2 trial with an interim futility assessment in patients with knee osteoarthritis. Pharmaceutical Statistics. 18(1). 39–53. 2 indexed citations

15.

Jin, Yan, Arie Regev, Krista M Phipps, et al.. (2017). Dose‐dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor. British Journal of Clinical Pharmacology. 84(1). 179–188. 21 indexed citations

16.

Smith, Claire, Yan Jin, Eyas Raddad, et al.. (2016). Applications of Bayesian statistical methodology to success criteria: A case study of a phase 2 design with interim futility assessment in patients with knee osteoarthritis. Osteoarthritis and Cartilage. 24. S185–S185. 1 indexed citations

17.

Jin, Yan, Claire Smith, David Monteith, et al.. (2016). LY2951742, a monoclonal antibody against CGRP, failed to reduce signs and symptoms of knee osteoarthritis. Osteoarthritis and Cartilage. 24. S50–S50. 11 indexed citations

18.

Yuen, Eunice, Bharvin K.R. Patel, Claire Smith, et al.. (2016). Abstract CT048: Population pharmacokinetics and pharmacodynamics for an oral Notch inhibitor, LY3039478, in the first-in-man study. Cancer Research. 76(14_Supplement). CT048–CT048. 3 indexed citations

19.

Brandes, Alba A., Alain Carpentier, Santosh Kesari, et al.. (2016). A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. Neuro-Oncology. 18(8). 1146–1156. 204 indexed citations

20.

Walley, Rosalind, Claire Smith, Jeremy D. Gale, & Phil Woodward. (2015). Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study. Pharmaceutical Statistics. 14(3). 205–215. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact